Table 1.
Baseline characteristics of patients
| Parameter | Value |
|---|---|
| Age (years) | 51.2 ± 14.8 |
| Gender | |
| Male | 131 (61.5%) |
| Female | 82 (28.5%) |
| Comorbidities | |
| Obesity (BMI ≥30 kg/m2) | 61 (28.6%) |
| Overweight (BMI 25–29.9 kg/m2) | 78 (36.6%) |
| Diabetes mellitus | 44 (20.6%) |
| Hypertension | 57 (26.7%) |
| Smoking history | 49 (23%) |
| Cardiac disease | 13 (6.1%) |
| Lung disease | 6 (2.8%) |
| Renal disease | 1 (0.4%) |
| Any comorbidity† | 108 (50.7%) |
| Hepatic steatosis by CTL/S | 104 (48.8%) |
| Main CT findings/tomographic phase | |
| Ground‐glass opacities/phase 1 | 61 (34.2%) |
| Crazy‐paving pattern/phase 2 | 31 (17.4%) |
| Consolidation/phase 3 | 54 (30.3%) |
| Cicatricial changes/phase 4 | 32 (17.9%) |
| Additional CT findings | |
| Air bronchogram | 73 (34.2%) |
| Atoll sign | 27 (12.6%) |
| Tree‐in‐bud nodules | 4 (1.8%) |
| Lymph node enlargement | 41 (19.2%) |
| Cardiac enlargement | 27 (12.6%) |
| Main pulmonary artery dilatation | 50 (23.4%) |
| Coronary artery calcification | 67 (31.4%) |
| Pleural effusion | 4 (1.8%) |
| CO‐RADs 13 /RSNA Expert Consensus 14 | |
| 1 (normal)/no pneumonia | 103 (48.3%) |
| 2 (low‐risk)/atypical findings | 2 (0.8%) |
| 3 (indeterminate)/indeterminate findings | 4 (1.8%) |
| 4 (high risk)/indeterminate findings | 9 (4.2%) |
| 5 (very high risk)/typical findings | 95 (44.6%) |
| 6 (positive RT‐PCR)/NA | 213 (100%) |
| Chest CT severity score | |
| ≤19 | 110 (51.6%) |
| ≥20 | 103 (48.4%) |
†
Includes obesity; overweight; diabetes mellitus; hypertension; smoking history; and cardiac, lung, and renal diseases.
BMI, body mass index; CT, computed tomography; NA, not applicable; RT‐PCR, real time polymerase chain reaction.